Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold-Reference-Cited by-同舟云学术

Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold

Published:2020 Issue:10 Volume:11 Page:1112-1135
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Baillache Daniel J.¹²³⁴⁵^ORCID,Unciti-Broceta Asier¹²³⁴⁵^ORCID

Affiliation:

1. Cancer Research UK Edinburgh Centre

2. Institute of Genetics and Molecular Medicine

3. University of Edinburgh

4. Edinburgh EH4 2XR

5. UK

Abstract

Pyrazolo[3,4-d]pyrimidines have become of significant interest for the medicinal chemistry community as a privileged scaffold for the development of kinase inhibitors to treat a range of diseases, including cancer.

Funder

Medical Research Scotland

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/MD/D0MD00227E

Reference131 articles.

1. Cancer statistics, 2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Why is cancer drug discovery so difficult?

4. Hallmarks of Cancer: The Next Generation

5. The Protein Kinase Complement of the Human Genome

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer and Antibacterial Activeness of Fused Pyrimidines: Newfangled Updates;Bioorganic Chemistry;2024-12

2. Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction;Bioorganic Chemistry;2024-09

3. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023);Journal of Medicinal Chemistry;2024-07-12

4. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

5. Design, spectroscopic characterizations, and biological investigation of oxospiro[chromine-4,3-indolene]-based compounds as promising antiproliferative EGFR inhibitors and antimicrobial agents;Molecular Diversity;2024-06-09